EULAR Policy Statements

EULAR develops evidence-based policy to inform Government decisions related to rheumatic musculoskeletal diseases and research and communicates views to key decision makers.

 

 

Related information

About EULAR Advocacy

EU Advocacy is a key activity for a European umbrella organisation like the European Alliance of Associations for Rheumatology (EULAR).

See more


EULAR Advocacy Partnerships

EULAR is committed to partner with organisations and scientific medical societies at a EU and national level towards improving research funding, social policy legislation and quality of care; assisting advocacy actions on the national and international levels around rheumatic and musculoskeletal diseases (RMDs).

See more


EULAR RheumaMap

A Research Roadmap to transform the lives of people with Rheumatic and Musculoskeletal Diseases.

See more


EU Parliament Interest Group on RMDs

The European Parliament Interest Group on Rheumatic and Musculoskeletal Diseases (RMDs) was created in 2009 on the occasion of World Arthritis Day (12 October) and was re-established during the current parliamentary term (2014-2019).

See more


Links to other organisations

Partnerships that help to increase the knowledge of the organisations involved and the impact they can have on the political stage.

See more


Questions and Answers on RMDs

EULAR description on Rheumatic and Musculoskeletal Diseases (RMDs)

See more